Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management
The advent of immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment, significantly improving patient outcomes across multiple malignancies. Nonetheless, these therapies are associated with immune-related adverse effects, including cardiotoxicity, which remains a critical concern. T...
Guardat en:
| Autors principals: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2025-07-01
|
| Col·lecció: | Journal of Cardiovascular Development and Disease |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2308-3425/12/7/270 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
